From beyond the grave: Use of medical information from the deceased to guide care of living relatives
From beyond the grave: Use of medical information from the deceased to guide care of living relatives
Purpose of review: In order to inform patients of their genetic risks, access to the medical records and/or stored samples of their relatives is often helpful. We consider some of the obstacles to such access when these relatives are deceased and suggest how they might be navigated.
Recent findings: We explore an issue first highlighted in 2004 by Lucassen et al. (Br Med J 328:952-953, 2004) and re-evaluate it in the wake of novel technologies and mainstreaming of genomic medicine. We find that it is still an issue in practice despite professional guidelines advocating access to familial information (Joint Committee on Genomics in Medicine 2019) and that the Human Tissue Act 2004 is often wrongly constructed as a reason to block access. Access is often obstructed by failing to adopt the necessary relational concept of autonomy that applies in genetic medicine as reported by Horton and Lucassen (Curr Genet Med Rep 7:85-91, 2019) and by considering confidentiality to be absolute, even after death. In response to a recent legal case about the confidentiality of genetic test results, and their disclosure to family members (ABC v St George's Healthcare NHS Trust 2020), Dove et al. (J Med Ethics 45:504-507, 2019) suggested that a duty to consider the interests of genetic relatives could co-exist alongside a duty of confidentiality to a patient. In this way, healthcare professionals can use professional judgement about the relative value of genetic information to family members. This is equally relevant in accessing deceased relatives' information. A recent systematic review found a high level of acceptability of postmortem use of genetic data for medical research amongst participants and their relatives, and it is reasonable to assume that this acceptability would extend to clinical practice as reported by Bak et al. (Eur J Hum Genet 28:403-416, 2020).
Summary: Within clinical practice, access to medical records/samples of deceased relatives is often obstructed unnecessarily, potentially resulting in harm to the living relatives seeking advice. Consent to such access is important but need not be the bureaucratic hurdle that is often imposed.
Access to records, Confidentiality, Consent, Genetics, Next of kin
147-153
Tadros, Shereen
7c223479-c65e-4110-b52f-4146299afb96
Carley, Helena
499137fd-5fd3-4039-be28-eb24d7e738ef
Lucassen, Anneke
2eb85efc-c6e8-4c3f-b963-0290f6c038a5
December 2020
Tadros, Shereen
7c223479-c65e-4110-b52f-4146299afb96
Carley, Helena
499137fd-5fd3-4039-be28-eb24d7e738ef
Lucassen, Anneke
2eb85efc-c6e8-4c3f-b963-0290f6c038a5
Tadros, Shereen, Carley, Helena and Lucassen, Anneke
(2020)
From beyond the grave: Use of medical information from the deceased to guide care of living relatives.
Current Genetic Medicine Reports, 8, .
(doi:10.1007/s40142-020-00196-6).
Abstract
Purpose of review: In order to inform patients of their genetic risks, access to the medical records and/or stored samples of their relatives is often helpful. We consider some of the obstacles to such access when these relatives are deceased and suggest how they might be navigated.
Recent findings: We explore an issue first highlighted in 2004 by Lucassen et al. (Br Med J 328:952-953, 2004) and re-evaluate it in the wake of novel technologies and mainstreaming of genomic medicine. We find that it is still an issue in practice despite professional guidelines advocating access to familial information (Joint Committee on Genomics in Medicine 2019) and that the Human Tissue Act 2004 is often wrongly constructed as a reason to block access. Access is often obstructed by failing to adopt the necessary relational concept of autonomy that applies in genetic medicine as reported by Horton and Lucassen (Curr Genet Med Rep 7:85-91, 2019) and by considering confidentiality to be absolute, even after death. In response to a recent legal case about the confidentiality of genetic test results, and their disclosure to family members (ABC v St George's Healthcare NHS Trust 2020), Dove et al. (J Med Ethics 45:504-507, 2019) suggested that a duty to consider the interests of genetic relatives could co-exist alongside a duty of confidentiality to a patient. In this way, healthcare professionals can use professional judgement about the relative value of genetic information to family members. This is equally relevant in accessing deceased relatives' information. A recent systematic review found a high level of acceptability of postmortem use of genetic data for medical research amongst participants and their relatives, and it is reasonable to assume that this acceptability would extend to clinical practice as reported by Bak et al. (Eur J Hum Genet 28:403-416, 2020).
Summary: Within clinical practice, access to medical records/samples of deceased relatives is often obstructed unnecessarily, potentially resulting in harm to the living relatives seeking advice. Consent to such access is important but need not be the bureaucratic hurdle that is often imposed.
This record has no associated files available for download.
More information
Accepted/In Press date: 20 October 2020
e-pub ahead of print date: 24 November 2020
Published date: December 2020
Additional Information:
© The Author(s) 2020.
Keywords:
Access to records, Confidentiality, Consent, Genetics, Next of kin
Identifiers
Local EPrints ID: 452444
URI: http://eprints.soton.ac.uk/id/eprint/452444
ISSN: 2167-4876
PURE UUID: e146c907-2f88-4b2d-9737-a8b00ea95ece
Catalogue record
Date deposited: 11 Dec 2021 06:43
Last modified: 17 Mar 2024 02:54
Export record
Altmetrics
Contributors
Author:
Shereen Tadros
Author:
Helena Carley
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics